Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
A new multidrug re-induction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine (TVTG) for relapsed or refractory acute leukemia.
